User talk:Ewingdo
Ewingdo, you are invited to the Teahouse!
[edit]![]() |
Hi Ewingdo! Thanks for contributing to Wikipedia. We hope to see you there!
Delivered by HostBot on behalf of the Teahouse hosts 16:09, 25 April 2020 (UTC) |
display-authors
[edit]Hi, just wanted to let you know that |display-authors=
in citation templates doesn't work like in this change. Please take a moment to familiarize yourself with the documentation, as well as how vauthors works. Let me know if you have questions. --Izno (talk) 16:59, 24 September 2020 (UTC)
- Actually, unless there are MANY authors, do not use display authors, and if doing so, set it at four. Kudos for improving journal refs, but use initials for first names rather than full name. And vauthors= better than last1, first 1, last 2, first 2... David notMD (talk) 09:32, 23 October 2020 (UTC)
- When you removed class-Stub, should have replaced it with Start or higher. I set the atony article at C-class. David notMD (talk) 09:32, 23 October 2020 (UTC)
Your thread has been archived
[edit]![]() |
Hi Ewingdo! The thread you created at the Wikipedia:Teahouse,
|
Your submission at Articles for creation: Richard Gorlin has been accepted
[edit]![](http://upload.wikimedia.org/wikipedia/commons/thumb/2/21/AFC-Logo.svg/50px-AFC-Logo.svg.png)
Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions.
The article has been assessed as Start-Class, which is recorded on its talk page. Most new articles start out as Stub-Class or Start-Class and then attain higher grades as they develop over time. You may like to take a look at the grading scheme to see how you can improve the article.
If you have any questions, you are welcome to ask at the help desk. Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.
If you would like to help us improve this process, please consider
.Thanks again, and happy editing!
97198 (talk) 11:46, 12 December 2020 (UTC)List of Surgeons nomination
[edit]Hello Ewingdo: I love the work that you do on Wikipedia. In your work highlighting key contributors to medicine and surgery, have you considered Russel Nelson MD, PhD? He was instrumental in developing the heart-lung machine in 1951 allowing open-heart surgeries to take place. He has been recognized for his pioneering work in open-heart surgery in the state of Utah, has been awarded a presidential chair at the University of Utah School of Medicine, and several other awards from the American Heart Association and the American College of Cardiology. I've included some outside links for your perusal. I welcome your thoughts on this nomination. CheckDO (talk) 19:30, 15 November 2021 (UTC)
ArbCom 2021 Elections voter message
[edit]Invitation to take part in a survey about medical topics on Wikipedia
[edit]Dear fellow editor,
I am Piotr Konieczny, a sociologist of new media at Hanyang University (and User:Piotrus on Wikipedia). I would like to better understand Wikipedia's volunteers who edit medical topics, many associated with the WikiProject Medicine, and known to create some of the highest quality content on Wikipedia. I hope that the lessons I can learn from you that I will present to the academic audience will benefit both the WikiProject Medicine (improving your understanding of yourself and helping to promote it and attract new volunteers) and the wider world of medical volunteering and academia. Open access copy of the resulting research will be made available at WikiProject's Medicine upon the completion of the project.
All questions are optional. The survey is divided into 4 parts: 1 - Brief description of yourself; 2 - Questions about your volunteering; 3 - Questions about WikiProject Medicine and 4 - Questions about Wikipedia's coverage of medical topics.
Please note that by filling out this questionnaire, you consent to participate in this research. The survey is anonymous and all personal details relevant to your experience will be kept private and will not be transferred to any third party.
I appreciate your support of this research and thank you in advance for taking the time to participate and share your experiences! If you have any questions at all, please feel free to contact me at my Wikipedia user page or through my email listed on the survey page (or by Wikipedia email this user function).
The survey is accessible through the LINK HERE.
Piotr Konieczny
Associate Professor
Hanyang University
If you wish to opt-out of future mailings, please remove yourself from the mailing list. MediaWiki message delivery (talk) 22:24, 13 December 2021 (UTC)
Fredrick Arthur Willius
[edit]Good morning! I was wondering if you had any tips or advice on how I can increase the quality of the article? Thanks so much! -Evansknight (talk) 14:38, 28 February 2022 (UTC)
Orphaned non-free image File:Robert Arthur Bruce MD.jpeg
[edit]![⚠](http://upload.wikimedia.org/wikipedia/commons/thumb/3/34/Ambox_warning_blue.svg/35px-Ambox_warning_blue.svg.png)
Thanks for uploading File:Robert Arthur Bruce MD.jpeg. The image description page currently specifies that the image is non-free and may only be used on Wikipedia under a claim of fair use. However, the image is currently not used in any articles on Wikipedia. If the image was previously in an article, please go to the article and see why it was removed. You may add it back if you think that that will be useful. However, please note that images for which a replacement could be created are not acceptable for use on Wikipedia (see our policy for non-free media).
Note that any non-free images not used in any articles will be deleted after seven days, as described in section F5 of the criteria for speedy deletion. Thank you. --B-bot (talk) 17:24, 2 August 2022 (UTC)
ArbCom 2022 Elections voter message
[edit]Hello! Voting in the 2022 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 12 December 2022. All eligible users are allowed to vote. Users with alternate accounts may only vote once.
The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.
If you wish to participate in the 2022 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}}
to your user talk page. MediaWiki message delivery (talk) 01:45, 29 November 2022 (UTC)
ArbCom 2023 Elections voter message
[edit]Hello! Voting in the 2023 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 11 December 2023. All eligible users are allowed to vote. Users with alternate accounts may only vote once.
The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.
If you wish to participate in the 2023 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}}
to your user talk page. MediaWiki message delivery (talk) 00:58, 28 November 2023 (UTC)
Ways to improve AIM-HIGH (trial)
[edit]Hello, Ewingdo,
Thank you for creating AIM-HIGH (trial).
I have tagged the page as having some issues to fix, as a part of our page curation process and note that:
Both of the reference are from the trialists (the main study and an extended follow-up), so there is no idependent evidence of notability from the page as it currently stands. Do such sources exist? If so, it would be great to add them. It might be better to merge to Niacin#As lipid-modifying medication, where it is not described.
The tags can be removed by you or another editor once the issues they mention are addressed. If you have questions, leave a comment here and begin it with {{Re|Klbrain}}
. Remember to sign your reply with ~~~~
. For broader editing help, please visit the Teahouse.
Delivered via the Page Curation tool, on behalf of the reviewer.
Klbrain (talk) 15:30, 10 July 2024 (UTC)
I have sent you a note about a page you started
[edit]Hi Ewingdo. Thank you for your work on List of cardiovascular clinical trials. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Thanks for creating this new list. It is of course incomplete, and always will be, but it's a start. For lists that are potentially open-ended, it's best to have an inclusion critera; for example, perhaps a minimum trial size. I don't think that the column formatting is necessary of helpful; leaving the lists unconstrained by formatting is generally better for accessibility. You have empty sections, and it might be worth either filling them or deleting them - new sections can always be added if they're needed. For future pages, consider building them in draft space until they're more complete and ready to move to the main space.
To reply, leave a comment here and begin it with {{Re|Klbrain}}
. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
Klbrain (talk) 08:28, 11 July 2024 (UTC)
Ways to improve RALES (trial)
[edit]Hello, Ewingdo,
Thank you for creating RALES (trial).
I have tagged the page as having some issues to fix, as a part of our page curation process and note that:
None of the article are specifically about the RALES trial; they mention it, and cite it, along with other similar trials. Most research research studies are cited, and such citations aren't enough to establish notability. If independent notability can't be estabilished it may be better to merge the contents to spironolactone as an alternative to deletion.
The tags can be removed by you or another editor once the issues they mention are addressed. If you have questions, leave a comment here and begin it with {{Re|Klbrain}}
. Remember to sign your reply with ~~~~
. For broader editing help, please visit the Teahouse.
Delivered via the Page Curation tool, on behalf of the reviewer.
Klbrain (talk) 18:16, 11 July 2024 (UTC)
Jeffrey Leiden Updates
[edit]Hi Ewingdo. I noticed you at Wikipedia:WikiProject_Biography/Members where you mentioned you are interested in "medicine and science related biographies." I recently posted an edit request at Talk:Jeffrey_Leiden#Updates, who is the CEO of Vertex Pharmaceuticals. The request is just three simple edits, (the fourth having already been implemented). I am hoping you won't mind taking a look at the request and implementing it if you agree they improve the article. JohnDatVertex (talk) 08:27, 12 July 2024 (UTC)